This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Centers for Disease Control and Prevention is seeking public comments on how Americans with chronicpain are successfully treating their symptoms. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.”
The Centers for Disease Control and Prevention is still seeking public comments on how Americans with chronicpain are successfully treating their symptoms. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
The daily use of cannabis by patients with chronicpain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine. ’
In adults with chronicpain , what are the harms of Kratom or other plant-based substances for treatment of chronicpain? In adults with chronicpain, what are the harms of cannabinoids? In adults with chronicpain, what are the benefits of cannabinoids? A Statement from the AHRQ.
Chronicpain —a condition that affects 50.2 Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronicpain relief have been somewhat hazy…up until now. New guidelines for cannabis in chronicpain were recently published by a group of Canadian researchers.
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”
The legislation “would direct VA to conduct clinical research with varying forms of medicinal cannabis to evaluate the safety and effects of cannabis on health outcomes of veterans with PTSD and veterans with chronicpain.” ” Click here to send a message to your lawmakers and encourage them to cosponsor the bill. .
Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse.
Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.
Those suffering from chronicpain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy.
The objective of this study was to determine how the use of medical cannabis affects prescribed opioid usage in chronicpain patients. The objective of this study was to determine how the use of medical cannabis affects prescribed opioid usage in chronicpain patients. Peer Reviewed Medical Study .
CBD could “significantly reduce opioid use and improve chronicpain and sleep quality among patients who are currently using opioids for pain management”, according to a new study. Data were collected at three different time points: baseline, 4, and 8 weeks. Ninety-seven patients completed the 8-week study.
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Men were more likely than women to treat pain with cannabis.
Their data suggests that ADHD causes later cannabis use, which may support the notion that THC is used to self medicate (although ADHD is associated with heavier use of many drugs). Endometriosis is a poorly-understood condition causing severe chronicpain and alterations in a woman’s menstrual cycle. Cannabis and ADHD.
Chronicpain patients who used cannabis saw sustained improvement in their condition over time, according to the results of a recently released study. An abstract of the research, “No pain, all gain? The data revealed a sustained improvement in the participants’ symptoms. More Research Needed For ChronicPain.
BY NORML Analysis: Marijuana Use Data Fails to Support “Gateway Hypothesis” POSTED ON MAY 6, 2021 Boise, Idaho: Claims that the initiation of marijuana use is independently linked to the later use of other controlled substances are not supported by longitudinal data, according to a study published in the Journal of Experimental Criminology.
To varying degrees, the three most common uses of medical marijuana in Massachusetts, Maine, and Maryland were to treat chronicpain, anxiety, and back and neck problems. of patients reported chronicpain as their primary condition, while in Connecticut 70.4% Severe chronicpain 35,866 30.5% Cancer 5,717 4.9%
Primary conditions included neurological diseases such as MS and epilepsy, chronicpain from autoimmune diseases like fibromyalgia, back pain, cancer, insomnia, and psychiatric disorders such as anxiety, depression, and PTSD.
They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients. The TGA recently released a new medical cannabis dashboard detailing a variety of information on both SAS-A and SAS-B approvals.
Enters into the ChronicPain Market with Psychedelics. This acquisition is focused on becoming the first and only company solving the puzzle of chronicpain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. 2 Pain 1994 Apr;57(1):5-15. billion in 2030.
For an engineer like Rick, who understood the value of evidence and data, it was a revelation. Cancer patients, folks with chronicpain, people suffering from conditions their doctors couldn’t fixthey all found their way to Rick’s door. Something clicked in Rick’s mind. And he never turned anyone away.
The case report built off data self-study complied by an Institute colleague and combined it with past reports of colorblind individuals who experienced vision improvements after consuming psilocybin. Test data showed that the subject experienced peak partial vision improvement around eight days after consuming psilocybin.
Researchers followed chronicpain patients and found something fascinating: the group using just 2.5 to 5mg of THC got almost the same pain relief as people taking much higher doses we’re talking 64% pain reduction versus 71%. That’s roughly equivalent to a few grains of rice in terms of the actual medicine.
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronicpain. About RYAH Group, Inc. RYAH Group, Inc.
A June 2022 research study conducted in Ontario Canada (where cannabis-based medicine is legal at the federal level), assessed how chronicpain patients view the use of cannabis-based products for medicinal purposes. Do you think that most patients viewed cannabinoid-based therapeutics as an effective pain remedy?
Alongside a team of researchers, he will assess 1,000 participants who have been actively consuming opioids for pain relief for a minimum of three months. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study.
Cannabis has been used for centuries to manage chronicpain from all sources and, as a recent study highlights, its positive effects extend to migraines. Other Research Findings. Of the 40 million sufferers in the U.S., 28 million are women.
Contrary to some narratives of decline, recent data reveals a more nuanced pictureone of evolution, resilience, and an urgent need for continued support. Verified Dispensary Licensing Data: As of February 2025, the Cannabis Control Commission (CCC) reports 87 expired or surrendered Medical Treatment Center (MTC) licenses.
Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol To collect this data, Veriheal surveyed thousands of patients between the ages of 15 and 27 who signed up for our services between March 2023 and April 2024. Chronicpain and “other” are the second highest reasons.
The study, based on survey data and published in the Journal of Cannabis Research, showed “that CBD users take the drug to manage self-perceived anxiety, stress, sleep, and other symptoms, often in low doses, and these patterns vary by demographic characteristics.”. Stress, anxiety, and quality of sleep. The Rapid Spread of CBD Usage.
Currently and historically the most common qualifying condition reported by medical marijuana patients is chronicpain. In fact, according to an analysis by Boehnke et al, chronicpain was the qualifying condition reported by medical marijuana patients nearly 65 percent of the time (according to 2016 data).
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
This data aligns with Americans’ rising acceptance of cannabis. The most popular qualifying conditions continue to be chronicpain and PTSD, some of which may be related to the pandemic. million patients in 2022, a sharp increase from the 3.1 The study also analyzed peoples’ reasons for registering.
The participants also reported that medical marijuana has been beneficial for their various health conditions, which include chronicpain, anxiety, and insomnia. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.
The report did not set out a timeline for usage guidelines, citing the need for more data. The other increases research into the efficacy of marijuana in treating chronicpain and PTSD. Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. FEDERAL NEWS.
It has improved the quality of life for those dealing with chronicpain, nausea, seizures, and other medical conditions. MMJ is known for its efficacy in treating various medical issues, including chronicpain, epilepsy, multiple sclerosis, and more.
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.
If you’re dealing with a lack of sleep from an overactive mind, anxiety, or chronicpain, weed strains with sedating, anti-anxiety, and pain-relieving properties may be able to help you get the shut eye you deserve. Below are recommendations mostly based on extrapolated animal data and studies on essential oils from plants.
The data will also help doctors and researchers boost their knowledge, and assist in the creation of better alternative health products, according to People Science. Tan said that in addition to the survey, participants will also monitor their sleep with a smartphone app, and send the data to People Science for analysis.
Data suggests that cannabis can be helpful for women with difficulties or dysfunction attaining orgasm. Endometriosis This is a condition in which tissue similar to the uterine lining grows outside the uterus, which can result in severe pain, scarring, and infertility. There may be a wide variety of causes for this syndrome.
Currently and historically, the most common qualifying condition reported by medical marijuana patients is chronicpain. In fact, according to Boehnke et al’s analysis of 2016 data, chronicpain was the qualifying condition reported by medical marijuana patients nearly 65 percent of the time. Boehnke et al.
“Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” Cannabis Helps “Treatment-Resistant” Patients Two new prospective cohort studies build upon this work with additional real-world data that may well wind up in future reviews.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content